Filing Flows › Regen BioPharma (RGBP) › Q3 FY26 › vs Q3 FY25
Regen BioPharma (RGBP) Q3 FY26 vs Q3 FY25 (year over year)
Regen BioPharma's revenue rose $0 (0%) from $59K in Q3 FY25 to $59K in Q3 FY26.
Regen BioPharma, Q3 FY26: revenue $59K (0% year over year), operating margin 41.5%, net loss $638K, operating cash flow −$24K. The chart draws each line against Q3 FY25, the increases inside each band.
Every line
| Line | Q3 FY26 | Q3 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $59K | $59K | $0 | 0% |
| Net loss | $638K | $167K | $470K | +281% |
| Costs & expenses | $697K | $226K | $470K | +208% |
| Operating costs | $35K | $100K | −$65K | -65% |
| Interest & other, net | $662K | $127K | $536K | +423% |
| General & admin | $14K | $31K | −$17K | -55% |
| Other operating costs | $21K | $69K | −$48K | -70% |
| Operating cash sources | $638K | $167K | $470K | +281% |
| Working capital & other | $614K | $111K | $502K | +451% |
| Cash used in operations | $24K | $56K | −$32K | -57% |
| Net loss absorbed | $638K | $167K | $470K | +281% |
Questions
How much did Regen BioPharma's revenue grow year over year in Q3 FY26?
Regen BioPharma's revenue rose $0 (0%) from $59K in Q3 FY25 to $59K in Q3 FY26.